News related to Bentyl (Dicyclomine) and/or conditions it is approved for
Lexicon Announces Positive Phase 2 Results Of LX1031 In Non-Constipating Irritable Bowel Syndrome
Source: GastroIntestinal / Gastroenterology News From Medical News Today [2009.11.13]
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced that the company's investigational new drug, LX1031, a tryptophan hydroxylase (TPH) inhibitor, demonstrated positive results in clinically important parameters for the treatment of non-constipating irritable bowel syndrome (IBS).
Pharmos Announces Results Of Phase 2b Irritable Bowel Syndrome Study
Source: Irritable-Bowel Syndrome News From Medical News Today [2009.09.15]
Pharmos Corporation (Pink Sheets: PARS) announced the results of its Phase 2b Dextofisopam clinical trial to evaluate safety and efficacy of the compound in irritable bowel syndrome. Although the primary efficacy variable (% of weeks responding for adequate overall relief of IBS symptoms) did not reach statistical significance, the percentage responding for the Dextofisopam 200 mg group was higher than that observed for the Phase 2a trial.
Contrary To Insoluble Fiber, Soluble Fiber Is An Effective Treatment For Irritable Bowel Syndrome
Source: Irritable-Bowel Syndrome News From Medical News Today [2009.08.28]
The first trial in increasing dietary fiber in a primary care setting is published on bmj.com today. It reports that soluble fiber (psyllium) is an effective treatment for irritable bowel syndrome (IBS). On the other hand, insoluble fiber such as bran may worsen symptoms. Irritable bowel syndrome is characterized by abdominal pain and an irregular bowel habit. It affects about 10 percent of the population.
Alternative Treatment For Irritable Bowel Syndrome When Conventional Therapy Has Failed
Source: Irritable-Bowel Syndrome News From Medical News Today [2009.08.13]
IBS remains a common intestinal disorder causing significant discomfort and poor quality of life in patients who have the diagnosis. TCAs have been shown to improve abdominal pain in patients with IBS; however, there is insufficient evidence of global symptom relief. The search for an optimal treatment to improve symptoms and quality of life in IBS remains ongoing. A research article published in the World Journal of Gastroenterology addresses this problem.
Is Somatic Hypersensitivity A Predictor Of Irritable Bowel Syndrome?
Source: Irritable-Bowel Syndrome News From Medical News Today [2009.07.23]
Although visceral hypersensitivity is considered a hallmark feature of IBS, conflicting evidence exists regarding somatic hypersensitivity in this patient population. Several investigators have found no evidence for heightened somatic pain sensitivity in IBS patients. Also, others have reported similar cold presser pain tolerance in IBS patients and controls. These conflicting findings may result from differing somatic pain testing procedures.
Irritable Bowel Syndrome in Children
Source: MedicineNet Intestinal Gas (Belching, Bloating, Flatulence) Specialty [2009.06.24]
Title: Irritable Bowel Syndrome in Children
Category: Diseases and Conditions
Created: 6/24/2009
Last Editorial Review: 6/24/2009
Irritable Bowel Syndrome
Source: MedicineNet Intestinal Gas (Belching, Bloating, Flatulence) Specialty [2009.03.04]
Title: Irritable Bowel Syndrome
Category: Diseases and Conditions
Created: 2/25/2002
Last Editorial Review: 3/4/2009
Irritable Bowel Syndrome Symptoms
Source: MedicineNet tegaserod Specialty [2005.10.31]
Title: Irritable Bowel Syndrome Symptoms
Category: Health Facts
Created: 10/19/2005
Last Editorial Review: 10/31/2005
Soluble Fibre But Not Bran Effective At Treating Symptoms Of IBS
Source: Irritable-Bowel Syndrome News From Medical News Today [2009.09.04]
Soluble fibre (psyllium) is an effective treatment for irritable bowel syndrome (IBS), but insoluble fibre (bran) may worsen symptoms, according to the first trial of increasing dietary fibre in a primary care setting, published on bmj.com. Irritable bowel syndrome is characterised by abdominal pain and an irregular bowel habit, and affects about 10% of the population.
Chronic Pelvic Pain Syndromes: Clinical, Urodynamic, And Urothelial Observations
Source: Irritable-Bowel Syndrome News From Medical News Today [2009.08.03]
UroToday.com - Patients with pain can present with various symptom complexes that include interstitial cystitis, vulvodynia, irritable bowel syndrome, myofascial pain or various causes of dyspareunia but when carefully evaluated, the majority have very similar findings.
IBS study shows benefit from targeted antibiotics
Source: The Doctors Lounge - Gastroenterology
The study findings support the theory that irritable bowel syndrome (IBS) is caused by bacterial overgrowth in the gut.
|
